We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

27 hedge funds and large institutions have $8.4M invested in VolitionRx Ltd in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

13% more funds holding

Funds holding: 24 → 27 (+3)

0.28% less ownership

Funds ownership: 0.74% → 0.46% (-0.28%)

5% less capital invested

Capital invested by funds: $8.89M → $8.4M (-$484K)

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Leisure Capital Management
California
+$149K
2
BCM
Bridgeway Capital Management
Texas
+$51.4K
3
VF
Virtu Financial
New York
+$39.3K
4
UBS Group
UBS Group
Switzerland
+$34.3K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
+$20.6K

Top Sellers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
-$2.68M
2
SC
Skylands Capital
Wisconsin
-$62K
3
KCM
Knoll Capital Management
Florida
-$61.9K
4
BCM
BlueCrest Capital Management
Jersey
-$22K
5
TRCT
Tower Research Capital (TRC)
New York
-$7.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
RFM
26
Royal Fund Management
Florida
$2K +$2.06K +50 New
SC
27
Skylands Capital
Wisconsin
– -$62K -1,543 Closed
BCM
28
BlueCrest Capital Management
Jersey
– -$22K -551 Closed
TRCT
29
Tower Research Capital (TRC)
New York
– -$7.73K -188 -96%
CPA
30
Cowen Prime Advisors
New York
– -$6K -141 Closed
1
2

VNRX Hedge Fund Activity: Q3 2018 in Review

27 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q3 2018, worth a combined $8.4M — down 5.4% from $8.89M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VNRX positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Leisure Capital Management, opening a new position worth an estimated $149K. The largest seller was Lagoda Investment Management, cutting an estimated $2.68M.

  • 27 institutional investors held VolitionRx Ltd (VNRX) as of Q3 2018, up from 24 in Q2 2018.
  • Funds reported $8.4M of VolitionRx Ltd stock for Q3 2018, down 5.4% quarter-over-quarter.
  • 6 funds opened new VolitionRx Ltd positions in Q3 2018 and 3 closed out, a net change of +3 holders.
  • The largest VolitionRx Ltd buyer in Q3 2018 was Leisure Capital Management, an estimated $149K added.
  • The largest VolitionRx Ltd seller in Q3 2018 was Lagoda Investment Management, an estimated $2.68M sold.

Based on aggregated 13F filings for Q3 2018.